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There is ample evidence for both beneficial and harmful involvement of the immune sys-
tem in tumor development and spread. Immune cell recruitment to tumors is essential 
not only for the success of anticancer immune therapies but also for tumor-induced 
immune suppression. Now that immune-based therapies are playing an increasingly 
important role in treatment of solid tumors such as metastatic melanomas, precise 
analysis of the in vivo contributions of different leukocyte subsets in tumor immunity has 
become an even greater priority. Recently, this goal has been markedly facilitated by the 
use of intravital microscopy, which has enabled us to visualize the dynamic interactions 
between cells of the immune system and tumor targets in the context of the tumor 
microenvironment. For example, intravital imaging techniques have shed new light on 
T cell infiltration of tumors, the mechanisms of cancer cell killing, and how myeloid cells 
contribute to tumor tolerance and spread. This mini-review summarizes the recent 
advances made to our understanding of the roles of innate and adaptive immune cells in 
cancer based on the use of these in vivo imaging approaches.
Keywords: in vivo imaging, antitumor immune response, intravital microscopy, immune suppression, migration, 
cellular dynamics
inTRODUCTiOn
Immune infiltration is a common feature of most solid tumors, and the nature of these infiltrates 
has both prognostic and therapeutic implications. Now that immune therapies are gaining traction 
in the treatment of multiple types of cancer, it is becoming increasingly important to understand the 
complex interactions between immune cells and the tumor microenvironment. In particular, it is 
crucial to visualize these interactions in situ since the full complexity of the tumor microenvironment 
cannot be recapitulated in in vitro culture systems. Intravital imaging has proven to be an important 
tool to uncover the role of immune cells in tumor responses by revealing dynamics, interactions, 
spatial relationships, and distribution of leukocytes in tumor settings. Two-photon microscopy 
(Figure 1), as well as spinning disk and rapid resonant scanning confocal microscopy, provide low 
phototoxicity combined with high spatial resolution and allow for repeated scanning of tissue, thus 
providing temporal information about cellular migration and interactions.
Both lymphoid and myeloid compartments have been demonstrated to play important but 
frequently opposing roles in tumor responses. This mini-review summarizes some of the recent 
insights obtained with intravital imaging techniques into both positive and negative interactions 
between immune cells and tumor deposits in vivo, and how this approach is helping understand the 
FigURe 1 | Two-photon microscopy can be used to visualize immune cells and structures in normal tissue and within the tumor microenvironment. 
(A) Jablonski diagram comparing one-photon and two-photon excitation. Excitation occurs as fluorophores are excited from the ground to the first electron state. 
While one-photon excitation occurs through the absorption of a single photon, near simultaneous absorption of two lower-energy photons via short-lived 
intermediate states is required for two-photon excitation. After either excitation, the fluorophore relaxes to the lowest energy level of the first state. The subsequent 
fluorescence emission processes for both relaxation modes are the same. (B) Two-photon microscopy used to visualize blood vessels (red) and Lysozyme M+ 
myeloid cells (blue) in murine skin. (C) A single optical section of a Lewis lung carcinoma (blue) infiltrated by lysozyme M+ myeloid cells (green), blood vessels (red) 
visualized using two-photon microscopy.
2
Torcellan et al. In Vivo Imaging in Cancer
Frontiers in Immunology | www.frontiersin.org March 2017 | Volume 8 | Article 309
role of non-malignant tumor components in tumor progression 
and responses to therapy.
viSUALiZing MYeLOiD CeLLS in 
CAnCeR
Infiltration of tumors by cells from the myeloid lineage is usually 
associated with accelerated primary tumor growth and metastasis 
as well as poor prognosis (1). A recent study focusing on the timing 
of immune cell infiltration found that myeloid cell recruitment to 
the lung in response to metastatic B16 melanoma occurred in coor-
dinated “waves,” beginning with the arrival of neutrophils within 
minutes of tumor cell appearance. Conventional monocytes, and 
finally macrophages, patrolling monocytes, and dendritic cells 
(DCs) followed neutrophil infiltration (2). A study in fluorescent 
translucent zebra fish larvae showed that neutrophils are able to 
recognize and interact with preneoplastic cells when they are still 
single cells or small clusters of clones (3). Macrophages were the 
second immune cell to be recruited to the preneoplastic clones, 
and the presence of macrophages was independent of neutrophil 
infiltration (4). While our understanding of the properties and 
functions of myeloid cells is complicated by the use of varying 
markers for identifying the cell populations involved, as well as 
plasticity associated with these cells types, the use of intravital imag-
ing techniques has led to a clearer understanding of the different 
roles of tumor-infiltrating myeloid lineage cells in tumorigenesis.
neutrophils
It is becoming increasingly apparent that neutrophils, in addition 
to being the first immune cell subset to be recruited to sites of 
inflammation, also play an important role in cancer pathogen-
esis. While some antitumor functions for neutrophils have been 
reported (5, 6), recent evidence points to a role for them in 
promoting tumor spread and metastasis (7–10). Using intravital 
imaging, neutrophils have been shown to enhance adhesion 
of metastasizing tumor cells within the liver sinusoids (11). 
A subsequent study by Ferri and colleagues demonstrated that 
neutrophil extracellular traps (NETs), one of the mechanisms 
utilized by neutrophils to capture and destroy pathogens, can also 
play a role in sequestration of circulating tumor cells thereby pro-
moting metastasis (12). In an in vivo mouse model, NETs induced 
by infection trapped intravenously injected circulating lung carci-
noma cells leading to the formation of hepatic micrometastases. 
Furthermore, DNAse treatment or neutrophil elastase inhibition 
to disrupt NET formation prevented metastases, highlighting the 
role of NETs in tumor spread (12).
Macrophages
Tumor-associated macrophages have been implicated in many 
different facets of tumorigenesis, largely as immunosuppressive 
cells associated with poor patient prognosis [reviewed in Ref. 
(13)]. One interesting imaging study has revealed that tumor-
infiltrating macrophages in a mouse breast cancer model are the 
main immune subset targeted by bisphosphonate drugs. This find-
ing may provide a mechanism whereby bisphosphonates improve 
disease outcome (14). Time-lapse recordings of macrophages 
labeled with fluorescent nanoparticles demonstrate that they clus-
ter within tumors, show relatively low motility, and engage in pro-
longed interactions with tumor cells via cytoplasmic protrusions 
(15). Intravital microscopy has also provided important insights 
into some of the mechanisms used by macrophages to promote 
tumor growth and spread. For example, multiphoton imaging 
in mice has revealed that the interaction between macrophages 
and tumor cells establishes a microenvironment essential for the 
intravasation of tumor cells (16). Utilizing confocal intravital 
microscopy in combination with anti-colony-stimulating factor-1 
receptor antibody treatment, it was possible to demonstrate both 
the depletion of tumor-associated macrophages and DCs, as well 
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as the inhibition of their survival and the accumulation of cells 
within the tumor stroma (17). Furthermore, when treatment with 
the antibody was prolonged, it delayed growth of the primary 
tumor, decreased lung metastasis, and reduced tumor vascularity.
Notably, macrophages have been found at specific sites 
within tumors called “Tumor MicroEnvironment of Metastasis” 
(TMEM), which have been implicated in tumor cell intravasation 
(18). Using intravital high-resolution two-photon microscopy in 
a mouse mammary tumor model, Harney and colleagues showed 
that perivascular macrophages within TMEM were associated 
with increased vascular permeability and tumor intravasation 
(19). These findings applied not just to the mouse mammary 
cancer model, but to human xenograft models and human meta-
static breast cancer as well, highlighting the enhancing role of 
macrophages in tumor metastasis.
Macrophages have also been associated with the development 
of metastatic lesions at distal sites. For instance, CCR2-expressing 
monocytes and macrophages can interact with tumor-derived 
CCL2 and aid the migration of macrophages to lung metastases 
in a breast cancer model (20). Furthermore, three-dimensional 
reconstructed confocal images of dissected mouse lungs (com-
mon site of metastasis in this model) showed significantly fewer 
tumor cells and macrophages after treatment with anti-CCL2 
antibody. Significantly, a similar interaction was important for the 
development of lung metastases in human breast cancer patients, 
with high CCL2 expression and macrophage infiltration indica-
tive of a poor prognosis (20). Likewise, in a recent study utilizing a 
mouse model of colorectal cancer, tumor-associated macrophages 
derived from CCR2+ monocytes played a crucial role in develop-
ment of the extracellular matrix, revealing a novel pro-tumor 
mechanism for macrophages (21). Fluorescence lifetime imaging 
microscopy has been used to visualize macrophages within the 
stroma of mouse mammary tumors (22). In this study, the authors 
utilized the endogenous fluorescence of flavin adenine dinucleo-
tide (FAD) and glycolytic-like nicotinamide adenine dinucleotide 
(NAD) to detect tumor-associated macrophages through imag-
ing windows implanted in mouse skin. Macrophages infiltrating 
mammary tumors were identified by their unique metabolic 
signature of high FAD and NAD and thus could be distinguished 
from the surrounding tumor cells. Notably, since this imaging 
approach relies on endogenous fluorescence to visualize immune 
cells in tumors rather than transgenic or fluorescent labels, it has 
potential for clinical applications (22, 23).
Dendritic Cells
Dendritic cells constitute an important link between the innate 
and adaptive immune systems. They take up and transport anti-
gen from peripheral tissues to the lymph nodes or spleen where 
they present it to T  cells. As the central regulators of adaptive 
immune responses, most subsets of DCs play a crucial role in 
T  cell-mediated antitumor immunity [reviewed in Ref. (24)]. 
For example, two-photon imaging of OVA-expressing MCA101 
tumors revealed that DCs are organized into a mesh-like pattern 
within the tumor, where they engage in antigen-dependent stable 
contacts with OVA-specific CD8+ T  cells. Interestingly, T  cell 
infiltration was restricted to DC rich areas, where, instead of 
promoting T cell immunity, the DCs may trap T cells and limit 
the antitumor function of these cells (25). Live imaging has also 
demonstrated a role for CCR7-dependent trafficking of intratu-
moral CD103+ DC from the tumor to draining lymph nodes (26). 
This migratory DC subset could either stimulate lymph node 
CD8+ T cells directly or transfer antigen to resident myeloid cells. 
Furthermore, CCR7 expression levels in human tumors directly 
correlated with CD141+ DCs and T  cell infiltration, as well as 
improved survival in metastatic melanoma patients. This result 
links DC migration from tumors to draining lymph nodes with 
T cell infiltration and antitumor immunity.
Intravital imaging of DCs has revealed that in addition to 
their role in stimulating T  cell responses, they also influence 
immune responses through interactions with other leukocytes 
subsets involved in tumor immunity. For instance, two-photon 
microscopy has showed that within draining lymph nodes, 
tumor-derived antigen is readily transferred from subcapsular 
macrophages to follicular DCs for presentation to B cells, indi-
cating a potential role for DCs in inducing humoral responses, 
which are common in melanoma patients (27). Furthermore, 
in vivo imaging of leukemic B cells in a transgenic mouse model 
of B cell chronic lymphocytic leukemia showed that intratumor 
B cells can interact directly with follicular DCs, accelerating B cell 
proliferation and clinical progression (28).
Dendritic cells can also interact with natural killer (NK) cells, 
leading to their increased activation. Two-photon microscopy 
demonstrated that after lipopolysaccharide treatment, the extent 
of NK cell activation correlated with prolonged interaction with 
DCs in the lymph node. Once activated, these NK cells infiltrated 
a proximal tumor and impaired tumor growth (29). Thus, intra-
vital microscopy has revealed several previously unappreciated 
aspects of the interplay between the tumor microenvironment 
and cells of the innate immune system.
CeLLULAR DYnAMiCS OF LYMPHOiD 
CeLLS in TUMOR ReSPOnSeS
T cells constitute one of the key elements of the tumor microen-
vironment but due to the large number of distinct T cell subsets, 
their role in tumor immunity is especially complex. Some tumor-
infiltrating T cell subsets, such as CD8+ cytotoxic T lymphocytes 
(CTLs), have important antitumor functions and their presence 
often correlate with a better prognosis (30). In contrast, suppressive 
T cell subsets, such as regulatory T (Treg) cells, impair antitumor 
responses and promote tumor growth, their presence within 
tumors therefore generally being associated with poor disease 
outcome (31, 32). Furthermore, T  cell-based immune therapies 
aimed at either boosting the function of CTLs to combat cancer 
or inhibiting Treg cells that subdue antitumor responses represent 
some of the most promising recent developments in the treatment 
of solid tumors (33–35). Just as for myeloid cells, intravital imaging 
has provided important insights into the function of lymphoid cells 
in cancer that could not have been obtained using other methods.
Cytotoxic T Lymphocytes
Given the prominent role that CTLs play in tumor destruction, it 
is unsurprising that their dynamics in antitumor responses have 
been the subject of intense investigation. Intravital microscopy 
FigURe 2 | Photolabeling extends the utility of intravital microscopy for analysis of immune cell migration in cancer. (A) A schematic for labeling 
tumor-infiltrating cells. Two-photon microscopy is used to photoconvert cells within a specific region of interest within the tumor deposit. Microscopy and/or flow 
cytometry can then be used to detect photolabeled cells in distal organs. (B) An example of two-photon photoconversion of a single region (red) within a lymph 
node of a Kaede photoconvertible transgenic mouse. Non-photoconverted cells (green), LYVE-1+ lymphatics/collagen (blue). Scale bar represents 100 µm. (C) A 
single optical section of a murine lymph node containing photoconverted cells (red), non-photoconverted cells (green), LYVE-1+ lymphatics/collagen (blue). Scale bar 
represents 500 µm.
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has provided important clues about migration and function 
of these cells in tumor settings. For instance, in  vivo imaging 
revealed that during the tumor regression stage, CTLs migrate 
in a random walk in the presence of their cognate antigen and 
engage in sustained interactions with intratumoral macrophages 
and tumor cells (36). Furthermore, antigen expression by tumor 
cells determined the depth of tumor infiltration by CTLs and their 
motility within tumors in a murine model of EL4 thymoma (37). 
Interestingly, during the early phase of tumor rejection, tumor-
specific CTL migration was slow and frequently interrupted 
by interactions with antigen-expressing tumor cells. However, 
this migration became more rapid in the later phase of tumor 
rejection in areas of extensive tumor cell death. Intratumoral 
CTL motility was reduced in comparison to tumor-infiltrating 
NK  cells, due to the long-lasting contacts between CTLs and 
their targets (38). The dynamics of tumor elimination by CTLs 
have also been visualized and quantitated using in vivo imaging 
(39). Adoptively transferred tumor-specific CTLs were shown 
to engage directly with individual tumor cells and then to kill 
them. Surprisingly, this process was estimated to take an average 
of 6 h, suggesting such a lapse in time might be one of the factors 
limiting the efficacy of antitumor immunity at least in this model. 
While factors that control intratumoral CTL migration are still 
being elucidated, the cell adhesion molecule CD44 has emerged 
as a critical regulator of this process. CD44 engagement stabilized 
T  cell polarity and promoted T  cell migration within tumors, 
which has the potential to lead to more efficient screening of 
tumor cells and immune surveillance (40).
To obtain longitudinal information about immune responses in 
developing tumors, Shrieber and colleagues implanted windows 
into the back skin of mice through which tumors could be repeat-
edly imaged. This enabled them to visualize T cell infiltration of 
tumors following the adoptive transfer of tumor-specific T cells. 
Their analysis revealed stromal interaction and vessel destruction 
(41). The tumor vessel destruction was initiated by perivascular 
T cells, while T cell interactions with the cross-presenting tumor 
stroma led to enhanced T  cell effector function and bystander 
elimination of tumor cells.
Despite the fact that intravital microscopy is not currently 
feasible in patients, real-time imaging in unfixed sections of fresh 
human tumors has provided some insights into the dynamics of 
human tumor-infiltrating T cells ex vivo (42). CTL migration in 
the tumor stroma, where these T cells were more abundant, was 
slower compared to less populated tumor deposits. Interestingly, 
the collagen fibers in the tumor extracellular matrix affected 
intratumoral T  cell distribution and migration, acting as both 
a physical barrier and a guidance structure for CTLs. This sug-
gests that the extracellular matrix may influence tumor growth 
and could become the target of novel immunotherapies aimed at 
promoting T cell migration into tumors.
Treg Cells
Regulatory T cells play a critical role in the suppression of antitu-
mor immunity, and their dynamics and mechanism of action in 
cancer settings are of great interest. Analysis of Treg function in 
tumor-draining lymph nodes demonstrated that tumor-specific 
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Treg cells inhibit CTL lytic functions without impairing CTL 
motility or their ability to form conjugates with target cells. 
Interestingly, inhibition of CTL function could be reversed by 
Treg removal (43).
Furthermore, Treg interactions with DCs in tumor-draining 
lymph nodes have been associated with DC death (44). Two-
photon intravital microscopy revealed that this cell death was 
mediated by perforin and dependent on the presence of both 
the tumor and/or tumor antigens, suggesting this mechanism to 
be a pro-tumor response designed to limit the priming of CD8+ 
T cells. Consistent with this, Treg cell inactivation or depletion 
led to enhanced numbers of DCs and better T  cell priming in 
draining lymph nodes.
The pro-tumor role of tumor-experienced Treg cell interac-
tions with DCs was also investigated by Bauer and colleagues 
using two-photon microscopy (45). In this study, Treg cells that 
had encountered the tumor antigen in draining lymph nodes 
subsequently interacted with DCs within the tumor leading to 
the downregulation of costimulatory molecules CD80/86 on DC 
surface. Importantly, activation of tumor-infiltrating CTLs by 
Treg-conditioned DCs promoted CTL dysfunction via upregula-
tion of coinhibitory receptors PD-1 and Tim-3. Thus, imaging 
studies have been instrumental in uncovering the mechanisms of 
Treg suppression of antitumor immune responses.
B Cells
The role of B cells in cancer is still unclear. However, the antigen-
presenting capability of activated B  cells appears resistant to 
tumor microenvironment-induced immunosuppressive factors, 
such as IL-10 and TGF-β (46), suggesting that this immune subset 
may present an attractive target for immunotherapy. In an EL4 
murine lymphoma model, adoptively transferred activated B cells 
migrated to tumor-draining lymph nodes where they interacted 
with T  cells and induced antigen-specific CTL responses (47). 
Taken together, these findings highlight the potential of B cells as 
a cellular adjuvant for cancer immunotherapy.
COnCLUDing ReMARKS
Intravital microscopy is providing unique opportunities to 
observe immune cell migration and function in situ within both 
primary tumor deposits and secondary lymphoid organs where 
antitumor responses are initiated. Thus, we now have a better 
understanding of how CTLs find and kill their targets inside 
tumor deposits and how Treg cells can inhibit these processes, 
as well as the mechanisms utilized by myeloid cells to enhance 
cancer cell migration and spread. As immune therapies are 
poised to become a major weapon in cancer therapy, intravital 
imaging will be invaluable for monitoring in vivo effects of such 
therapies.
Another promising area for future investigations is visualizing 
the earliest interactions between immune cells and preneoplastic 
cells since this may provide insights into the early mechanisms 
that tumor cells utilize to alter immune cell functions. A better 
understanding of this process may lead to early intervention 
therapeutics or even prevention strategies.
Although intravital imaging provides a dynamic view of 
the tumor-immune system interplay, analysis is still limited to 
a relatively short imaging window (typically 30–120  min) and a 
single organ or tumor deposit at any one time. The development of 
new tools, including photoswitchable reporter mice, which allow 
labeling of cells following exposure to light of specific wavelengths, 
has the potential to overcome these limitations. For instance, 
photolabeling using transgenic mice expressing Kaede fluorescent 
protein, which can be irreversibly converted from green to red 
upon exposure to UV or violet light, has already been successfully 
used by us (48) and others to monitor immune cell migration over 
large distances (49). When used in combination with two-photon 
microscopy, photoswitchable reporters allow for precise micro-
anatomical labeling of selected regions of interest (50) and even 
individual cells (51, 52). This combination can be utilized to label 
cells within primary tumor deposits and track their fate, migration, 
and function both within as well as outside of the primary tumor 
(Figure 2). This approach will undoubtedly provide a powerful tool 
in understanding how immune cells migrate between lymphoid 
organs, primary tumors, and sites of metastasis.
The development of new fluorescent proteins and biosensors 
when combined with continuing improvements in imaging and 
analysis techniques will also shed further light on the complex 
dynamic interactions that occur in  vivo between the immune 
system and solid tumors.
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